Showing 441-460 of 644 for: Cochrane Systematic Reviews > Psychiatric and substance abuse 
- Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders
Cochrane Systematic Reviews, 2-Nov-2008
A large proportion of patients with anxiety disorders fail to respond to first-line medication interventions, despite evidence of the effectiveness of these agents.
- Pharmacotherapy for anxiety disorders in children and adolescents
Cochrane Systematic Reviews, 8-Jul-2009
Anxiety disorders are a potentially disabling group of disorders which are prevalent in childhood and adolescence. The recognition of the early onset of anxiety disorders, and their successful treatment with medication in adults, has led to the growing in
- Pharmacotherapy for dysthymia
Cochrane Systematic Reviews, 21-Jul-2003
Many drug treatments have been proposed for the treatment of dysthymia, but with so many potential comparisons it is not possible at the present time to determine which is the treatment of choice. There is a need to know whether the different classes of a
- Pharmacotherapy for post traumatic stress disorder (PTSD)
Cochrane Systematic Reviews, 25-Jan-2006
Post traumatic stress disorder (PTSD) is a prevalent and disabling disorder. Evidence that PTSD is characterised by specific psychobiological dysfunctions has contributed to a growing interest in the use of medication in its treatment.
- Pharmacotherapy for social anxiety disorder (SAnD)
Cochrane Systematic Reviews, 19-Oct-2017
Recognition is growing that social anxiety disorder (SAnD) is a chronic and disabling disorder, and data from early trials demonstrate that medication may be effective in its treatment. This systematic review is an update of an earlier review of pharmacot
- Physical exercise for sleep problems in adults aged 60+
Cochrane Systematic Reviews, 21-Oct-2002
The prevalence of sleep problems in adulthood increases with age. While not all sleep changes are pathological in later life, severe disturbances may lead to depression, cognitive impairments, deterioration of quality of life, significant stresses for car
- Physical health care monitoring for people with serious mental illness
Cochrane Systematic Reviews, 17-Jan-2014
Current guidance suggests that we should monitor the physical health of people with serious mental illness, and there has been a significant financial investment over recent years to provide this.
- Physician advice for smoking cessation
Cochrane Systematic Reviews, 31-May-2013
Healthcare professionals frequently advise people to improve their health by stopping smoking. Such advice may be brief, or part of more intensive interventions.
- Physostigmine for dementia due to Alzheimer's disease
Cochrane Systematic Reviews, 23-Apr-2001
The main pharmacological approach for the treatment of Alzheimer's disease (AD) has been based on the use of agents potentiating cholinergic transmission, particularly by inhibiting acetylcholinesterase (AChE), the enzyme that destroys acetylcholine after
- Pimozide for schizophrenia or related psychoses
Cochrane Systematic Reviews, 5-Nov-2013
Pimozide, formulated in the 1960s, continues to be marketed for the care of people with schizophrenia or related psychoses such as delusional disorder. It has been associated with cardiotoxicity and sudden unexplained death. Electrocardiogram monitoring i
- Piracetam for dementia or cognitive impairment
Cochrane Systematic Reviews, 26-Jan-2004
Piracetam is a drug that may enhance memory and other intellectual functions, but its usefulness in treating dementia is uncertain. It is, however, commonly prescribed for cognitive impairment and dementia in several countries of continental Europe.
- Placebo interventions for all clinical conditions
Cochrane Systematic Reviews, 20-Jan-2010
Placebo interventions are often claimed to substantially improve patient-reported and observer-reported outcomes in many clinical conditions, but most reports on effects of placebos are based on studies that have not randomised patients to placebo or no t
- Polyunsaturated fatty acid supplementation for schizophrenia
Cochrane Systematic Reviews, 19-Jul-2006
Limited evidence supports a hypothesis suggesting that the symptoms of schizophrenia may be the result of altered neuronal membrane structure and metabolism. The structure and metabolism is dependent on blood plasma levels of certain essential fatty acids
- Population-based biomedical sexually transmitted infection control interventions for reducing HIV infection
Cochrane Systematic Reviews, 17-Feb-2011
The transmission of sexually transmitted infections (STIs) is closely related to the sexual transmission of human immunodeficiency virus (HIV). Similar risk behaviours, such as frequent unprotected intercourse with different partners, place people at high
- Preventing occupational stress in healthcare workers
Cochrane Systematic Reviews, 1-Apr-2015
Healthcare workers can suffer from occupational stress as a result of lack of skills, organisational factors, and low social support at work. This may lead to distress, burnout and psychosomatic problems, and deterioration in quality of life and service p
- Print‐based self‐help interventions for smoking cessation
Cochrane Systematic Reviews, 9-Jan-2019
Many smokers give up smoking on their own, but materials that provide a structured programme for smokers to follow may increase the number who quit successfully.
- Problem solving skills for schizophrenia
Cochrane Systematic Reviews, 18-Apr-2007
The severe and long-lasting symptoms of schizophrenia are often the cause of severe disability. Environmental stress such as life events and the practical problems people face in their daily can worsen the symptoms of schizophrenia. Deficits in problem so
- Prompts to encourage appointment attendance for people with serious mental illness
Cochrane Systematic Reviews, 23-Apr-2001
Prompts to encourage attendance at clinics are often used in day-to-day practice by diligent carers of people with mental health problems. These may take the form of telephone prompting, financial incentives or issuing a copy of the referral letter to the
- Propentofylline for dementia
Cochrane Systematic Reviews, 16-Apr-2008
Propentofylline is a novel therapeutic agent for dementia that readily crosses the blood-brain barrier and acts by blocking the uptake of adenosine and inhibiting the enzyme phosphodiesterase. In vitro and in vivo its mechanism of action appears to be two
- Propylthiouracil for alcoholic liver disease
Cochrane Systematic Reviews, 15-Jun-2011
Randomised clinical trials have addressed the question whether propylthiouracil has any beneficial effects in patients with alcoholic liver disease.
